Literature DB >> 16687729

Lenalidomide and venous thrombosis in multiple myeloma.

Robert Knight, Robert J DeLap, Jerome B Zeldis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16687729     DOI: 10.1056/NEJMc053530

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  49 in total

1.  Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION study.

Authors:  S K Kumar; I Flinn; S J Noga; P Hari; R Rifkin; N Callander; M Bhandari; J L Wolf; C Gasparetto; A Krishnan; D Grosman; J Glass; E A Sahovic; H Shi; I J Webb; P G Richardson; S V Rajkumar
Journal:  Leukemia       Date:  2010-05-27       Impact factor: 11.528

2.  Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study.

Authors:  Sigurdur Y Kristinsson; Ruth M Pfeiffer; Magnus Björkholm; Lynn R Goldin; Sam Schulman; Cecilie Blimark; Ulf-Henrik Mellqvist; Anders Wahlin; Ingemar Turesson; Ola Landgren
Journal:  Blood       Date:  2010-03-18       Impact factor: 22.113

3.  Venous thromboembolic disease.

Authors:  Michael B Streiff; Paula L Bockenstedt; Spero R Cataland; Carolyn Chesney; Charles Eby; John Fanikos; Patrick F Fogarty; Shuwei Gao; Julio Garcia-Aguilar; Samuel Z Goldhaber; Hani Hassoun; Paul Hendrie; Bjorn Holmstrom; Kimberly A Jones; Nicole Kuderer; Jason T Lee; Michael M Millenson; Anne T Neff; Thomas L Ortel; Judy L Smith; Gary C Yee; Anaadriana Zakarija
Journal:  J Natl Compr Canc Netw       Date:  2011-07-01       Impact factor: 11.908

Review 4.  The underappreciated risk of thrombosis and bleeding in patients with myelofibrosis: a review.

Authors:  Devendra Kc; Lorenzo Falchi; Srdan Verstovsek
Journal:  Ann Hematol       Date:  2017-08-14       Impact factor: 3.673

Review 5.  Lenalidomide in myeloma.

Authors:  Seema Singhal; Jayesh Mehta
Journal:  Curr Treat Options Oncol       Date:  2007-04

6.  A phase II study of thalidomide and irinotecan for treatment of glioblastoma multiforme.

Authors:  Camilo E Fadul; Linda S Kingman; Louise P Meyer; Bernard F Cole; Clifford J Eskey; C Harker Rhodes; David W Roberts; Herbert B Newton; J Marc Pipas
Journal:  J Neurooncol       Date:  2008-07-26       Impact factor: 4.130

7.  Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines.

Authors:  Shaji K Kumar; Joseph R Mikhael; Francis K Buadi; David Dingli; Angela Dispenzieri; Rafael Fonseca; Morie A Gertz; Philip R Greipp; Suzanne R Hayman; Robert A Kyle; Martha Q Lacy; John A Lust; Craig B Reeder; Vivek Roy; Stephen J Russell; Kristen E Detweiler Short; A Keith Stewart; Thomas E Witzig; Steven R Zeldenrust; Robert J Dalton; S Vincent Rajkumar; P Leif Bergsagel
Journal:  Mayo Clin Proc       Date:  2009-12       Impact factor: 7.616

8.  Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006.

Authors:  D P Cronin-Fenton; F Søndergaard; L A Pedersen; J P Fryzek; K Cetin; J Acquavella; J A Baron; H T Sørensen
Journal:  Br J Cancer       Date:  2010-09-14       Impact factor: 7.640

9.  Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma.

Authors:  Christine Chen; Donna E Reece; David Siegel; Ruben Niesvizky; Ralph V Boccia; Edward A Stadtmauer; Rafat Abonour; Paul Richardson; Jeffrey Matous; Shaji Kumar; Nizar J Bahlis; Melissa Alsina; Robert Vescio; Steven E Coutre; Dennis Pietronigro; Robert D Knight; Jerome B Zeldis; Vincent Rajkumar
Journal:  Br J Haematol       Date:  2009-05-26       Impact factor: 6.998

10.  Front line treatment of elderly multiple myeloma in the era of novel agents.

Authors:  Marie-Dominique Venon; Aldo M Roccaro; Julie Gay; Anne-Sophie Moreau; Remy Dulery; Thierry Facon; Irene M Ghobrial; Xavier Leleu
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.